Daniel Havas
Psychogenics (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Parkinson's Disease Mechanisms and Treatments, Nuclear Receptors and Signaling, Advanced MRI Techniques and Applications, Advanced Neuroimaging Techniques and Applications
Most-Cited Works
- → Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 mice(2012)72 cited
- → Time course and progression of wild type α-Synuclein accumulation in a transgenic mouse model(2013)61 cited
- → The Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibitor CI-1011 Reverses Diffuse Brain Amyloid Pathology in Aged Amyloid Precursor Protein Transgenic Mice(2010)57 cited
- → A Longitudinal Study of Behavioral Deficits in an AβPP Transgenic Mouse Model of Alzheimer's Disease(2011)46 cited
- → Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice(2013)45 cited
- → Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form(2017)38 cited
- → Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD(2023)31 cited
- → Late‐stage α‐synuclein accumulation in TNWT‐61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging(2015)24 cited
- → Diffusion Kurtosis Imaging Detects Microstructural Alterations in Brain of α-Synuclein Overexpressing Transgenic Mouse Model of Parkinson’s Disease: A Pilot Study(2015)19 cited
- → BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains(2018)17 cited